Study of Utilization Patterns of Dimethyl Fumarate in Germany

Biogen930 enrolled

Overview

The primary objective of this study is to estimate the proportion of DMF use that is prescribed "on-label" versus "off-label". The secondary objectives are: To describe the demographic characteristics and medical history of DMF users; To describe prescription drug history and concomitant medication use of DMF users; To describe the duration of therapy in participants newly initiating DMF treatment; To describe the medical specialties of DMF prescribers.

Dimethyl fumarate will not be provided to participants as a part of this study.

Study Type

OBSERVATIONAL

Enrollment

930

Conditions

Multiple Sclerosis

Interventions

dimethyl fumarateDRUG

Off-Label Use: All participants \<18 years of age and participants without an MS diagnosis who are prescribed dimethyl fumarate On-Label Use: All participants \>18 years of age with an MS diagnosis who are prescribed dimethyl fumarate

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Key Inclusion Criteria: * New users of dimethyl fumarate will be included in the analysis Key Exclusion Criteria: * Patients for which data is not available for the 6 months period prior to the index date (baseline observational period) NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.

Locations (1)

Research Site

Leipzig, Saxony, Germany